Nodular Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most common form of skin cancer, and among its various subtypes, nodular basal cell carcinoma is the most frequently diagnosed. This article provides a comprehensive overview of nodular BCC, including its clinical features, histopathology, treatment options, and prognosis.

This subtype typically presents as a pearly, dome-shaped nodule with telangiectasias. It most commonly occurs on sun-exposed areas such as the face, neck, and ears. The lesion often has a rolled, translucent border and may ulcerate centrally, giving rise to the classic "rodent ulcer" appearance. Early detection and treatment are crucial to prevent local tissue destruction.

Clinical Features of Nodular BCC

Nodular BCC is characterized by a slow-growing, flesh-colored or pink papule or nodule. The surface is often smooth with telangiectatic vessels. As it enlarges, central ulceration may occur, and the lesion can become crusty or bleed. Unlike the superficial type of BCC, which grows horizontally, the nodular type tends to grow downward, invading deeper tissues if left untreated. This vertical growth pattern makes it more aggressive locally.

Histopathology and Diagnosis

Histologically, nodular BCC shows large, well-defined nests of basaloid cells in the dermis. The tumor cells have large, hyperchromatic nuclei and scant cytoplasm. Palisading of peripheral cells and stromal retraction artifact are characteristic. A diagnosis is confirmed by biopsy, which is essential for differentiating nodular from superficial BCC as well as from other skin neoplasms. Dermoscopy can aid in clinical diagnosis, revealing arborizing vessels and ulceration.

Differential diagnoses include molluscum contagiosum, intradermal nevus, and sebaceous hyperplasia. Biopsy is particularly important for lesions with atypical features or when nodular BCC is suspected in a cosmetically sensitive area.

Treatment Options for Nodular Basal Cell Carcinoma

Nodular basal cell carcinoma treatment depends on tumor size, location, and patient factors. The gold standard is surgical excision with clear margins, commonly using Mohs micrographic surgery for high-risk areas (e.g., face, eyelids) to achieve complete removal while sparing healthy tissue. Curettage and electrodesiccation may be used for small, low-risk nodules, but it offers lower cure rates for more aggressive subtypes.

Other treatment modalities include topical imiquimod or 5-fluorouracil for superficial lesions, but these are less effective for nodular BCC due to its depth. Photodynamic therapy (PDT) and radiotherapy are alternative options for patients who are not surgical candidates. The choice of therapy should be individualized, and recurrence risk must be monitored.

• Surgical excision: Standard for most nodular BCCs; cure rate >95%.
• Mohs surgery: Preferred for high-risk tumors; maximizes tissue preservation.
• Curettage and electrodesiccation: Suitable for small, superficial nodules; cure rate ~90%.
• Radiotherapy: Option for elderly or nonsurgical patients; long-term cosmetic outcomes are good.

Comparison with Superficial BCC

Understanding the difference between nodular and superficial types is important for treatment planning. Superficial BCC presents as an erythematous, scaly patch, often on the trunk, and grows horizontally. In contrast, nodular BCC is a papulonodular lesion with vertical growth. Superficial BCC responds well to topical therapies, while nodular BCC typically requires surgical excision.

Prognosis for nodular BCC is excellent with early treatment. Recurrence rates are low (less than 5%) after clear-margin excision. However, neglected tumors can invade deep structures, including cartilage, bone, and nerves, leading to significant morbidity. Regular skin surveillance is recommended, especially for patients with a history of nodular BCC or other skin cancers.

Prevention and Follow-Up

Preventive measures include sun protection, avoidance of tanning beds, and regular self-skin examinations. High-risk individuals, such as those with fair skin, blue eyes, and a history of sunburns, should undergo annual dermatologic screening. After treatment, follow-up visits at 6-12 month intervals are recommended to monitor for recurrence or new primary lesions.

In summary, nodular basal cell carcinoma is the most common and classic subtype of BCC. Its distinct clinical and histologic features allow for accurate diagnosis. Early surgical intervention provides excellent cure rates, highlighting the importance of prompt medical attention for any suspicious skin lesion.